Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 03, 2023

SELL
$201.05 - $221.7 $4.11 Million - $4.54 Million
-20,460 Reduced 40.95%
29,500 $5.93 Million
Q2 2023

Aug 02, 2023

SELL
$211.93 - $241.33 $3.09 Million - $3.52 Million
-14,600 Reduced 22.61%
49,960 $12.1 Million
Q1 2023

May 02, 2023

SELL
$213.32 - $257.83 $255,984 - $309,396
-1,200 Reduced 1.82%
64,560 $14.8 Million
Q4 2022

Feb 08, 2023

BUY
$203.72 - $248.97 $611,160 - $746,910
3,000 Added 4.78%
65,760 $15.5 Million
Q3 2022

Nov 07, 2022

BUY
$204.81 - $262.19 $5.79 Million - $7.41 Million
28,260 Added 81.91%
62,760 $12.9 Million
Q2 2022

Aug 10, 2022

SELL
$213.86 - $277.87 $64,158 - $83,361
-300 Reduced 0.86%
34,500 $8.09 Million
Q1 2022

May 12, 2022

BUY
$259.82 - $298.18 $103,928 - $119,272
400 Added 1.16%
34,800 $9.18 Million
Q4 2021

Jan 28, 2022

SELL
$271.6 - $314.21 $1.19 Million - $1.38 Million
-4,390 Reduced 11.32%
34,400 $10.8 Million
Q3 2021

Nov 04, 2021

SELL
$274.82 - $308.34 $69.1 Million - $77.5 Million
-251,324 Reduced 86.63%
38,790 $10.9 Million
Q2 2021

Aug 04, 2021

SELL
$251.87 - $278.14 $5.69 Million - $6.29 Million
-22,600 Reduced 7.23%
290,114 $80 Million
Q1 2021

Apr 30, 2021

SELL
$204.88 - $255.03 $10.3 Million - $12.9 Million
-50,400 Reduced 13.88%
312,714 $79.8 Million
Q4 2020

Feb 08, 2021

BUY
$186.91 - $214.42 $5.37 Million - $6.17 Million
28,756 Added 8.6%
363,114 $73.9 Million
Q3 2020

Oct 23, 2020

BUY
$167.03 - $201.3 $838,824 - $1.01 Million
5,022 Added 1.52%
334,358 $62.9 Million
Q2 2020

Aug 05, 2020

SELL
$113.31 - $182.44 $3.88 Million - $6.24 Million
-34,200 Reduced 9.41%
329,336 $54.7 Million
Q1 2020

May 07, 2020

BUY
$104.32 - $195.28 $8.17 Million - $15.3 Million
78,356 Added 27.48%
363,536 $45.9 Million
Q4 2019

Feb 10, 2020

SELL
$163.48 - $173.61 $866,444 - $920,133
-5,300 Reduced 1.82%
285,180 $48.2 Million
Q3 2019

Nov 07, 2019

BUY
$159.77 - $178.1 $10.3 Million - $11.5 Million
64,400 Added 28.49%
290,480 $48.8 Million
Q2 2019

Aug 08, 2019

BUY
$144.16 - $172.9 $32.6 Million - $39.1 Million
226,080 New
226,080 $39.1 Million
Q1 2019

May 07, 2019

SELL
$123.7 - $156.3 $705,090 - $890,910
-5,700 Closed
0 $0
Q4 2018

Feb 05, 2019

SELL
$120.82 - $174.09 $4.93 Million - $7.1 Million
-40,800 Reduced 87.74%
5,700 $720,000
Q3 2018

Nov 06, 2018

SELL
$167.67 - $188.27 $7.04 Million - $7.91 Million
-42,004 Reduced 47.46%
46,500 $8.08 Million
Q2 2018

Aug 08, 2018

BUY
$160.33 - $189.41 $3.2 Million - $3.78 Million
19,940 Added 29.08%
88,504 $15.9 Million
Q1 2018

May 04, 2018

SELL
$161.53 - $178.11 $1.03 Million - $1.14 Million
-6,400 Reduced 8.54%
68,564 $11.1 Million
Q4 2017

Feb 01, 2018

BUY
$147.99 - $163.95 $6.27 Million - $6.95 Million
42,400 Added 130.21%
74,964 $0
Q3 2017

Nov 13, 2017

BUY
$149.47 - $160.56 $4.87 Million - $5.23 Million
32,564
32,564 $4.92 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.7B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Lsv Asset Management Portfolio

Follow Lsv Asset Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lsv Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Lsv Asset Management with notifications on news.